| Website | algonomics.com |
| Category | BioTech |
| Phone | 32-(0)9-241-11-00 |
| info@algonomics.com | |
| Employees |
| TOTAL | $2.01M |
| FUNDING TOTAL | $2.01M |
| Venture Round, 6/07 Baekeland Funds Gemma Frisius Fonds TrustCapital VIB | €1.5M |
AlgoNomics is a Belgium based biotech company providing structural bioinformatics services to develop rationally designed therapeutics in the broad field of immunotherapy. AlgoNomics owns a rich, proprietary platform for structure-based protein and peptide design. The technology platform contains innovative tools to unravel protein-protein and protein-peptide interactions. AlgoNomics’ premier product is the Epibase® platform for T-cell epitope identification in different population groups, applied in the discovery of vaccines and therapeutic proteins.
